首页> 外文会议>International Baltic Conference of Engineering Materials and Tribology >Impact of Biphasic Calcium Phosphate Bioceramics on Osteoporotic Hip Bone Mineralization In Vivo Six Months After Implantation
【24h】

Impact of Biphasic Calcium Phosphate Bioceramics on Osteoporotic Hip Bone Mineralization In Vivo Six Months After Implantation

机译:双相磷酸钙生物陶瓷对植入六个月体内骨质疏松症骨矿化的影响

获取原文

摘要

Calcium phosphate bone substitutes are successfully used for local recovery of osteoporotic bone and filling of bone defects. Previous studies reveled that biphasic calcium phosphate (BCP) show better bioactivity in compare to pure calcium phosphate (CaP) or hydroxyapatite (HAp). Also increased porosity of material promotes better bone tissue response. Aim of this experiment was to evaluate immunohistologically response of osteoporotic bone of experimental animal to implantation of granules with hydroxyapatite/p-tricalcium phosphate (HAp/p-TCP) ratio of 90/10.CaP was synthesized by aqueous precipitation technique from calcium hydroxide and phosphoric acid and sintered granules in size range from 1.0 to 1.4 mm were prepared with pore sizes around 200 nm. Nine female rabbits with induced osteoporosis were used in this experiment. Six animals in study group underwent implantation of BCP in hip bone defect and three animals in control group left without BCP implantation. After 6 months animals were euthanized, bone samples collected and proceeded for detection of bone activity and repair markers: osteocalcin (OC), osteopontin (OP) and osteoprotegerin (OPG).Controls demonstrated the presence of experimental bone osteoporosis. In experimental group bone showed partially resolved bioceramic material and in some samples new bone formation near the granules was observed. Increase of OC and OPG up to twice as to compare to control group were detected as well.Implantation of BCP HAp/pTCP 90/10 bioceramic in osteoporotic rabbit bone increases expression of OC and OPG indicating the activation of osteoblastogenesis and bone mineralization in vivo.
机译:磷酸钙骨替代物成功地用于骨质疏松的骨的本地恢复和骨缺损的填充。以前的研究认为陶醉双相磷酸钙(BCP)表现出更好的生物活性在比较纯粹的磷酸钙(CAP)或羟基磷灰石(HAP)。也增加了材料的孔隙率促进更好的骨组织响应。该实验的目的是评估实验动物的骨质疏松的骨的与羟基磷灰石/对 - 磷酸三钙90 / 10.CaP的磷灰石(HAp / P-TCP)比颗粒的植入immunohistologically响应用含水沉淀技术从氢氧化钙和合成从1.0至1.4mm,用孔径制备磷酸和在尺寸范围内的烧结的颗粒大小约200纳米。九只雌兔诱发的骨质疏松在本实验中使用。六只动物在BCP的研究组接受植入髋关节骨缺损和三只动物在对照组没有留下植入BCP。 6个月动物安乐死后,骨样品收集并进行检测骨活性和修复标志物:骨钙蛋白(OC),骨桥蛋白(OP)和骨保护素(OPG).Controls证实实验骨质疏松的存在。在实验组显示出骨部分解决生物陶瓷材料和在一些样品中,观察到新骨形成的颗粒的附近。作为要比较的对照组中检测到作为BCP的HAp / PTCP 90/10在OC和OPG的骨质疏松兔骨髓增加表达的生物陶瓷的well.Implantation指示体内成骨细胞和骨矿化的活化OC和OPG的增加高达两倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号